stockportfolio.pro
Haemonetics Corporation Revenue 2009–2026
Haemonetics Corporation (HAE) annual revenue by fiscal year, computed from SEC filings.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2026 | $1.33B | -2.0% |
| FY 2025 | $1.36B | +4.0% |
| FY 2024 | $1.31B | +12.0% |
| FY 2023 | $1.17B | +17.7% |
| FY 2022 | $993.20M | +14.1% |
| FY 2021 | $870.46M | -11.9% |
| FY 2020 | $988.48M | +2.2% |
| FY 2019 | $967.58M | +7.0% |
| FY 2018 | $903.92M | +2.0% |
| FY 2017 | $886.12M | — |
| FY 2016 | $0 | -100.0% |
| FY 2015 | $910.37M | -3.0% |
| FY 2014 | $938.51M | +5.2% |
| FY 2013 | $891.99M | +22.6% |
| FY 2012 | $727.84M | +7.6% |
| FY 2011 | $676.69M | +4.8% |
| FY 2010 | $645.43M | — |
| FY 2009 | $0 | — |
Source: Haemonetics Corporation SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Haemonetics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHaemonetics Corporation — frequently asked questions
What is Haemonetics Corporation's revenue?
Haemonetics Corporation (HAE) reported revenue of $1.33B for fiscal year 2026, per its SEC filings.
Where does this data come from?
Figures are computed from Haemonetics Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.